Therefore, the heterogeneous expression of PD-L1 in tumor tissues and the dynamic changes limit the feasibility of PD-L1-related IHC analysis in tissue biopsy and the accuracy of PD-L1 as a predictor of treatment efficacy (59). Here, CD274 is linked to neoplasm.